- Home
- HIO vs ETON Comparison
HIO vs ETON Comparison
Compare HIO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIO
- ETON
- Stock Information
- Founded
- HIO 1993
- ETON 2017
- Country
- HIO United States
- ETON United States
- Employees
- HIO N/A
- ETON N/A
- Industry
- HIO Finance/Investors Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- HIO Finance
- ETON Health Care
- Exchange
- HIO Nasdaq
- ETON Nasdaq
- Market Cap
- HIO 374.7M
- ETON 388.3M
- IPO Year
- HIO N/A
- ETON 2018
- Fundamental
- Price
- HIO $3.84
- ETON $19.93
- Analyst Decision
- HIO
- ETON Strong Buy
- Analyst Count
- HIO 0
- ETON 3
- Target Price
- HIO N/A
- ETON $29.67
- AVG Volume (30 Days)
- HIO 305.3K
- ETON 337.5K
- Earning Date
- HIO 01-01-0001
- ETON 11-11-2025
- Dividend Yield
- HIO 10.33%
- ETON N/A
- EPS Growth
- HIO N/A
- ETON N/A
- EPS
- HIO N/A
- ETON N/A
- Revenue
- HIO N/A
- ETON $58,181,000.00
- Revenue This Year
- HIO N/A
- ETON $105.25
- Revenue Next Year
- HIO N/A
- ETON $40.84
- P/E Ratio
- HIO N/A
- ETON N/A
- Revenue Growth
- HIO N/A
- ETON 85.40
- 52 Week Low
- HIO $3.52
- ETON $6.00
- 52 Week High
- HIO $4.03
- ETON $23.00
- Technical
- Relative Strength Index (RSI)
- HIO 36.81
- ETON 57.76
- Support Level
- HIO $3.90
- ETON $19.48
- Resistance Level
- HIO $3.89
- ETON $23.00
- Average True Range (ATR)
- HIO 0.04
- ETON 1.07
- MACD
- HIO -0.01
- ETON 0.03
- Stochastic Oscillator
- HIO 12.50
- ETON 44.48
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.